BioSante granted The Hussman Foundation exclusive, worldwide rights to its GVAX melanoma vaccine

BioSante Pharmaceuticals Inc.

U.S. / Small-Cap Biopharma (<$1 billion)

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

John P. Hussman Foundation

U.S. / Non-Profit or Major Disease Foundation

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced